Efficacy and safety of PD-1/PD-L1 inhibitors alone or in combination in the treatment of metastatic or advanced renal cell carcinoma: a network meta-analysis

Efficacy and safety of PD-1/PD-L1 inhibitors alone or in combination in the treatment of metastatic or advanced renal cell carcinoma: a network meta-analysis

BackgroundThis study systematically reviews the efficacy and safety of the single or combined use of programmed factor 1 (PD-1)/programmed factor 1 ligand (PD-L1) inhibitors for treating metastatic or advanced renal cell carcinoma (RCC).MethodsRelevant articles were collected for meta-analysis throu...

Full description

Saved in:
Bibliographic Details
Main Authors: Dongli Zhang, Chong Shen, Weichuan Zhang, Haibin Chen, Jianjun Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
renal cell carcinoma
PD-1/PD-L1 inhibitor
efficacy
safety
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1524497/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items